|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
Fusion Protein Induces HER2/neu Signaling and Facilitates Repair of Injured EpitheliaDepartment of Microbiology, Immunology and Molecular Genetics (T.-H.H., S.L.M.) and the Molecular Biology Institute (S.L.M.), University of California, Los Angeles, Los Angeles, California
Tumor necrosis factor (TNF)-
genetically fused to the carboxyl terminus of a single-chain Fv (ScFv) antibody specific for the human HER2/neu (anti-HER2/neu ScFv-TNF-
) forms a homotrimeric structure that retains both TNF-
activity and the ability to bind HER2/neu. In contrast to anti-HER2/neu IgG3, anti-HER2/neu ScFv-TNF-
induces potent HER2/neu signaling, activating the downstream mitogen-activated protein kinase (MAPK) and Akt pathways in SKBR3 cells. Activation of MAPK and Akt by anti-HER2/neu ScFv-TNF-
inhibited the apoptosis of SKBR3 cells induced by actinomycin D. Remarkably, anti-HER2/neu ScFv-TNF-
facilitated the repair of injured epithelia. Accelerated wound healing required binding to HER2/neu but not TNF-
activity since anti-HER2/neu ScFv-TNF-
(S147Y), containing a mutant TNF-
with significantly decreased biological activity, demonstrated equivalent ability to facilitate wound healing and soluble HER2/neu inhibited the effect. These results suggest that trimeric anti-HER2/neu ScFv has the potential to facilitate wound healing. In addition, fusion with TNF-
provides a novel approach to producing polymeric antibodies.
Address correspondence to: Dr. Tzu-Hsuan Huang, Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Box 951489, Los Angeles, CA 90095-1489. E-mail: thhhuang{at}ucla.edu
This article has been cited by other articles:
![]() |
T.-H. Huang, F. Wu, G. B. Loeb, R. Hsu, A. Heidersbach, A. Brincat, D. Horiuchi, R. J. Lebbink, Y.-Y. Mo, A. Goga, et al. Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion J. Biol. Chem., July 3, 2009; 284(27): 18515 - 18524. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Rossi, D. M. Goldenberg, T. M. Cardillo, R. Stein, Y. Wang, and C.-H. Chang Novel Designs of Multivalent Anti-CD20 Humanized Antibodies as Improved Lymphoma Therapeutics Cancer Res., October 15, 2008; 68(20): 8384 - 8392. [Abstract] [Full Text] [PDF] |
||||